Novo Nordisk helps Canada resolve Ozempic issue
Americans were reportedly crossing the border seeking the diabetes drug with a strong weight-loss effect until barred from purchases.
by stine locke nielsen, translated by daniel pedersen
Danish drugmaker Novo Nordisk is in dialogue with authorities in Canada after Adrian Dix, minister of health in British Columbia, told the Wall Street Journal on Tuesday that Canada doesn’t want to become a supplier of diabetes drug Ozempic to the US market.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Americans prevented from buying Ozempic in British Columbia
For subscribers
